These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18765686)

  • 1. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
    Kim JH; Jung SY; Lee YJ; Song KJ; Kwon D; Kim K; Park S; Im KI; Shin HJ
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4010-6. PubMed ID: 18765686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
    Kim JH; Lee YJ; Sohn HJ; Song KJ; Kwon D; Kwon MH; Im KI; Shin HJ
    Int J Antimicrob Agents; 2008 Nov; 32(5):411-7. PubMed ID: 18762406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
    Goswick SM; Brenner GM
    J Parasitol; 2003 Aug; 89(4):837-42. PubMed ID: 14533700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiparasitic Activity of Auranofin against Pathogenic Naegleria fowleri.
    Peroutka-Bigus N; Bellaire BH
    J Eukaryot Microbiol; 2019 Jul; 66(4):684-688. PubMed ID: 30520183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.
    Debnath A; Tunac JB; Galindo-Gómez S; Silva-Olivares A; Shibayama M; McKerrow JH
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5450-7. PubMed ID: 22869574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
    Goswick SM; Brenner GM
    Antimicrob Agents Chemother; 2003 Feb; 47(2):524-8. PubMed ID: 12543653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary amoebic meningoencephalitis in an infant.
    Mittal N; Mahajan L; Hussain Z; Gupta P; Khurana S
    Indian J Med Microbiol; 2019; 37(1):120-122. PubMed ID: 31424023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
    Schuster FL; Guglielmo BJ; Visvesvara GS
    J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Novel Therapeutic Agent Miltefosine for the Treatment of Primary Amebic Meningoencephalitis: Report of 1 Fatal and 1 Surviving Case.
    Cope JR; Conrad DA; Cohen N; Cotilla M; DaSilva A; Jackson J; Visvesvara GS
    Clin Infect Dis; 2016 Mar; 62(6):774-6. PubMed ID: 26679626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Naegleria fowleri proteins linked to primary amoebic meningoencephalitis.
    Jamerson M; Schmoyer JA; Park J; Marciano-Cabral F; Cabral GA
    Microbiology (Reading); 2017 Mar; 163(3):322-332. PubMed ID: 28086072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oleic Acid Coated Silver Nanoparticles Showed Better
    Rajendran K; Anwar A; Khan NA; Aslam Z; Raza Shah M; Siddiqui R
    ACS Chem Neurosci; 2020 Aug; 11(16):2431-2437. PubMed ID: 31347828
    [No Abstract]   [Full Text] [Related]  

  • 12. Fatal primary meningoencephalitis caused by Naegleria fowleri.
    Shariq A; Afridi FI; Farooqi BJ; Ahmed S; Hussain A
    J Coll Physicians Surg Pak; 2014 Jul; 24(7):523-5. PubMed ID: 25052979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
    Soltow SM; Brenner GM
    Antimicrob Agents Chemother; 2007 Jan; 51(1):23-7. PubMed ID: 17060522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naegleria fowleri: pathogenesis, diagnosis, and treatment options.
    Grace E; Asbill S; Virga K
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6677-81. PubMed ID: 26259797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis.
    Linam WM; Ahmed M; Cope JR; Chu C; Visvesvara GS; da Silva AJ; Qvarnstrom Y; Green J
    Pediatrics; 2015 Mar; 135(3):e744-8. PubMed ID: 25667249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-amoebic activity of Pinus densiflora leaf extract against the brain-eating amoeba Naegleria fowleri.
    Lê HG; Kim W; Kang JM; Võ TC; Yoo WG; Cheong H; Na BK
    Parasites Hosts Dis; 2024 May; 62(2):169-179. PubMed ID: 38835258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a high- versus low-pathogenicity model of the free-living amoeba Naegleria fowleri.
    Burri DC; Gottstein B; Zumkehr B; Hemphill A; Schürch N; Wittwer M; Müller N
    Microbiology (Reading); 2012 Oct; 158(Pt 10):2652-2660. PubMed ID: 22878396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri.
    Zyserman I; Mondal D; Sarabia F; McKerrow JH; Roush WR; Debnath A
    Exp Parasitol; 2018 May; 188():36-41. PubMed ID: 29551628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphotericin B induces apoptosis-like programmed cell death in Naegleria fowleri and Naegleria gruberi.
    Cárdenas-Zúñiga R; Silva-Olivares A; Villalba-Magdaleno JA; Sánchez-Monroy V; Serrano-Luna J; Shibayama M
    Microbiology (Reading); 2017 Jul; 163(7):940-949. PubMed ID: 28721850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic glycan-specific antibody binding mediates protection during primary amoebic meningoencephalitis.
    Moseman AP; Chen C-w; Liang X; Liao D; Kuraoka M; Moseman EA
    Infect Immun; 2024 Oct; 92(10):e0018324. PubMed ID: 39235225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.